Overexpression of RhoA enhances peritoneal dissemination. RhoA suppression with Lovastatin may be useful for ovarian cancer.

Horiuchi A., Kikuchi N., Osada R., Wang C., Hayashi A., Nikaido T., Konishi I.

Research output: Contribution to journalArticlepeer-review

Original languageJapanese
Pages (from-to)2532-2539
JournalOncology Research
StatePublished - 2008
Externally publishedYes

Cite this